CHRNA3 p.Arg477Ser
c.1429C>A · rs751042207 · VCV2304521
Computational evidence
| Protein change | ||
| AlphaMissense | 0.9939 | likely pathogenic · top 5% in CHRNA3 |
|---|---|---|
| REVEL | 0.875 | moderately pathogenic-leaning |
| SaProt | LLR -14.50 | damaging |
| ⇒ AlphaMissense, REVEL and SaProt all call this damaging. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Pangolin | Δ0.29 | loss · gain 0.02 · not in the SpliceAI release · independent |
| Constraint at this position | ||
| Conservation | phyloP 8.6 | GERP -1.4, phastCons 1 |
| Regional constraint | o/e 0.85 | unconstrained · MANE · 24 kb · p 0.00014 · regional, not allelic |
| Overall | ||
| CADD | 26.8 | PHRED · no single calibrated threshold — expert panels disagree |
ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification
AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Finnishnot grpmax-eligible | 0.00156% | 63,926 |
| European (non-Finnish)grpmax | 0.000254% | 393,244 |
Finnish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- CHRNA3
- Protein
- p.Arg477Ser
- Coding
- c.1429C>A
- MANE Select
- NM_000743
- dbSNP
- rs751042207
- Type
- single nucleotide variant
- Location
- chr15:78596693 (GRCh38)
- Gene constraint
- LOEUF 1.065 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 81.97 · 5 PDB
- Residue 477
- a UniProt-annotated variant site (in baiprck; loss-of-function variant affecting ion transmembrane transport in response to acetylcholine; does not localize to plasma membrane); an α-helix
Similar variants
- CHRNA3 p.Arg477His Uncertain significance ★★ ⚠ same residue
- CHRNA3 p.Leu380Val Uncertain significance ★★ ⚠ same condition
- CHRNA3 p.Pro498Leu Uncertain significance ★★ ⚠ same condition
- CHRNA3 p.Ala127Val Uncertain significance ★ ⚠ same condition
- CHRNA3 p.Ala366Val Uncertain significance ★ ⚠ same condition
- CHRNA3 p.Arg16Trp Uncertain significance ★ ⚠ same condition
- CHRNA3 p.Arg238Trp Uncertain significance ★ ⚠ same condition
- CHRNA3 p.Arg408His Uncertain significance ★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/chrna3-p-arg477ser (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown